Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Increase in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 88,752 shares, an increase of 824.0% from the September 15th total of 9,605 shares. Currently, 3.9% of the company’s stock are sold short. Based on an average daily trading volume, of 4,634,429 shares, the short-interest ratio is currently 0.0 days.

Arcadia Biosciences Stock Performance

RKDA stock opened at $0.26 on Monday. The stock has a market cap of $636,698.70, a P/E ratio of -0.06 and a beta of 0.56. The stock’s fifty day simple moving average is $0.47 and its two-hundred day simple moving average is $0.79. Arcadia Biosciences has a 1-year low of $0.22 and a 1-year high of $5.72.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by ($1.53). The business had revenue of $1.44 million for the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Arcadia Biosciences in a research note on Tuesday, September 22nd. One analyst has rated the stock with a Sell rating. According to MarketBeat, the stock presently has an average rating of “Sell”.

Get Our Latest Research Report on Arcadia Biosciences

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing plant-based products and crop technologies designed to address health, nutrition and sustainability needs. The company has worked to improve the nutritional profile and agricultural performance of crops through biotechnology and plant-breeding programs.

Arcadia’s product portfolio has included GoodWheat, a line of wheat varieties and wheat-based foods developed to contain reduced levels of gluten and other targeted nutritional characteristics.

See Also

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.